More importantly, Srpx2 siRNA-loaded liposomes was intratracheally injected into mice during the “fibrotic” phase of the model, which is more applicable and reflective to the clinical management of IPF patients. The gene discussed is SRPX2; the disease is idiopathic pulmonary fibrosis.